Recursion Pharmaceuticals, Inc. officer Secora Michael is set to sell 15,000 Class A shares on 06/14/2024, as per the latest filing. The shares, valued at an aggregate market value of $139,081.62, were originally acquired on 06/13/2023 through a stock option exercise from the issuer, with payment made in cash on the same date. This planned transaction follows a series of sales over the past three months, where a total of 63,124 shares were sold for gross proceeds of $506,805.72.

Recursion Pharmaceuticals, Inc. officer Secora Michael is set to sell 15,000 Class A shares on 06/14/2024, as per the latest filing. The shares, valued at an aggregate market value of $139,081.62, were originally acquired on 06/13/2023 through a stock option exercise from the issuer, with payment made in cash on the same date. This planned transaction follows a series of sales over the past three months, where a total of 63,124 shares were sold for gross proceeds of $506,805.72.